Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report
Background: a patient with a history of tuberculosis (TB) has a risk up to 27% to develop recurrence within 2 years after being cured. Indonesia itself has more than 7,500 recurrent cases annually, regardless of reinfection or relapse. This is an important problem, as recurrent TB is associated with...
| Glavni autori: | , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Interna Publishing
2017-04-01
|
| Serija: | Acta Medica Indonesiana |
| Teme: | |
| Online pristup: | http://www.actamedindones.org/index.php/ijim/article/view/327 |